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factors, potentially related with the mentioned respiratory diseases prevalence, 
as age, sex, smoking habits were analyzed. Four groups were compared: 1) asthma 
patients, 2) COPD patients, 3) patients with other chronic conditions, and 4) global 
Spanish population. Results: Data from 21,007 adults was recorded. Prevalence 
of asthma was slightly above COPD (5.4% vs 4.7%), and 47.2% were suffering from 
chronic diseases. Asthma patients were younger than those with COPD (51y vs 
61y, as an average, respectively). Concerning EQ-5D results, the dimensions mainly 
affected either in COPD or asthma were, respectively, pain/discomfort (53.7% / 
38.7%), mobility (42% / 27.4%), usual activities (34.4% / 21.8%), and depression/anxi-
ety (32.4% / 25.4%). Based on the EQ-5D questionnaire, the QALYs calculation were 
0.75 for COPD and 0.90 for asthma patients, the latter results were similar to the 
other chronic conditions and to the global population. Health resources in COPD 
patients were significantly higher than in the other 3 groups analyzed, considering 
office visits (GPs/Specialists), hospitalization and emergency unit visits during the 
last year. ConClusions: Patients diagnosed with asthma have a similar HRQOL 
compared to the rest of the population, but COPD patients have it worse. COPD 
is also associated with a higher health resources consumption, which implies a 
relevant impact on the Spanish National Health System.
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objeCtives: As young students are more prone to smoking and associated dan-
gers it affects their health related quality of life (HRQoL). This study was done to 
assess the HRQoL and other associated factors affecting HRQoL among smokers 
and non-smokers who are students. Methods: In this exploratory study a pilot 
tested questionnaire was used to collect information regarding young students, 
demographics, BMI, food habits, alcohol consumption, family history of smoking 
as well as family history of diseases. For health related quality of life measurement 
both descriptive and visual analogue score (VAS) of EQ 5D 5L questionnaire ware 
used. The data collected was analyzed using SPSS 16.0.0. The test of significance 
was done by using Chi Square test for checking the associated habits and Mann 
Whitney U test is done to check the significance of association between HRQoL 
and smoking and other associated habits. Results: Total 126 students were 
included in the study. The age was 22.9±2.17 (Mean±SD) and BMI was 22.03±4.27 
(Mean±SD) and all of them were residing in an University town. 63 % of the stu-
dents were non-vegetarians and 44.8% were consuming alcohol at least once 
in a month. The mean EQ 5D visual analogue score of the studied population 
was found to be 83.3±11.5 (Mean±SD). The Chi square test showed the associa-
tion between smoking with family history of smoking, alcohol consumption and 
soft drinks consumption (p< 0.001, 0.001 and 0.05 respectively). Mann Whitney 
U test showed as significant difference in the VAS scores among smokers and 
non-smokers (p< 0.05). ConClusions: Health Related Quality of Life is severely 
compromised by smoking, hence there is an urgent need to create awareness 
among young students.
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objeCtives: The aim of this study is to evaluate the health related quality of life 
(HRQoL) and health care utilization in primary care (PC) patients with asthma 
treated with beclomethasone/formoterol. Methods: This study analyzed the 
HRQoL and health care utilization from a cohort of 65 patients over 6 months. 
Inclusion criteria were patients aged 18 years and older with moderate/severe per-
sistent asthma (GINA criteria) treated with beclomethasone/formoterol at least 1-3 
months before the inclusion in the study. Sociodemographic variables such as age, 
sex, duration of disease, severity of asthma, concomitant pathology were evalu-
ated. The evaluation of the HRQoL were measured with the Asthma Quality of Life 
Questionnaire (AQLQ), and two generic questionnaires, EuroQol-5D and SF-36. The 
evaluation of the health care utilization included visits to PC, visits of care nursing 
and visits to accident and emergency (A&E) department and admissions. Statistical 
analysis: average ± standard deviation (SD); frequency and proportions. Inferential 
statistics in terms of average HRQoL and health care utilization were calculated 
using T-Student, Chi-square and ANOVA. Results: Average patients were female 
(60%), aged 49 years old (SD 2.16) with disease duration of 92 months (SD 18.34). 
The average health care utilization was: 3.43 (SD 0.35) visits to PC and 1.42 (SD 
0.29) visits to nursing; analytical: 0.63 (SD 0.09); chest x-ray: 0.38 (± 0.08); ECG 0.32 
(SD 0.08). The average of exacerbations without hospital admission was 1.09 (SD 
0.19) and the A&E department visits of PC related with asthma was 0.43 (SD 0.11). 
Statistically significant differences (p < 0.05) and clinically significant between the 
beginning and end of the study on all forms of quality of life measured in these 
patients were found measured with AQLQ, EuroQol-5D and SF36. ConClusions: 
Beclomethasone/formoterol improved HRQOL in patients with asthma representing 
a good cost/utility relationship.
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objeCtives: The aim of this study was to assess impairment in health-related 
quality of life (HRQoL) of pulmonary tuberculosis (PTB) patients in Pakistan. This 
study also evaluated utility of various socio-demographic and clinical factors that 
it was easy to use, the screens were easy to read, and that they could sign on and 
move through the questions with no difficulty. Subjects from the Spanish-speaking 
countries had the lowest reported difficulty turning the device on, with higher 
levels of difficulty observed by the interviewers in China, who reported “somewhat” 
for two of the three respondents. Interviewers observed that the majority (n= 15) 
could “easily” or “very easily” use the device. ConClusions: Given the consistent 
ease-of-use findings in these diverse, device naïve subjects across 7 countries and 
the emphasis on subject training in clinical trials, it was determined that usability 
testing with future translations was unnecessary.
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objeCtives: The Nighttime Symptoms of COPD Instrument (NiSCI), developed 
through qualitative research with patients, includes six symptom items: cough-
ing, wheezing, shortness of breath, difficulty bringing up phlegm, chest conges-
tion, and tightness in the chest. A symptom severity score is computed based on 
these items. In situations where patient burden is a major consideration, a smaller 
set of items may be preferable. Clinicians identified coughing, wheezing, short-
ness of breath, and difficulty bringing up phlegm as the most relevant for COPD 
patients. Exploratory psychometric analyses were conducted for the symptom sum-
mary score based on these four items compared with all six items. Methods: 
Psychometric properties of the four-item versus six-item symptom summary scores 
were examined using phase 3 clinical trial data from a random split-half sample. 
Symptom summary scores were tested for: internal consistency using Cronbach’s 
Alpha; test-retest reliability using Intraclass Correlation Coefficients (ICC) and 
Concordance Correlation Coefficients (CCC); convergent validity using Spearman 
Rank Order Correlation Coefficients; and known-groups validity using ANOVA and 
Scheffe’s test for pair-wise comparisons. Results: Patients (n= 832) were aged 40–93 
years (mean 63.78 ±-9.07 [SD]) and 51% were male. Both scores were internally 
consistent and valid. Cronbach’s alpha was slightly higher for the six-item symp-
tom summary (0.85) versus the four-item symptom summary (0.78). ICC and CCC 
scores were 0.85 for the six-item and 0.84 for the four-item symptom summary 
scores. Likewise, construct validity and known-groups validity were similar for both 
scores (p> 0.05). ConClusions: The NiSCI symptom summary score based on four 
items has similar psychometric properties to the six-item symptom summary score. 
Both scores have measurement properties suitable for use in clinical trials. Further 
work will test the psychometric properties of the instrument administered with 
four items.
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objeCtives: Idiopathic pulmonary fibrosis (IPF) is a progressive disease charac-
terized by declining lung function, leading to debilitating limitations on activity 
which may negatively impact HRQOL. However, HRQOL data in this population 
are limited. The primary objective was to evaluate HRQOL in IPF using measures 
from the Patient Reported Outcomes Measurement Information System (PROMIS). 
The secondary objective was to examine the association between key symptoms 
and HRQOL. Methods: Individuals with IPF were recruited via patient advocacy 
organizations to complete an online survey consisting of PROMIS-29 health pro-
file, PROMIS-Dyspnea, dyspnea measured by Modified Medical Research Council 
Dyspnea Scale (MMRC), self-reported cough, and cough subscale of the ATAQ 
(A Tool to Assess Quality of life)-IPF. PROMIS-29 scores have mean= 50, SD= 10 in the 
US general population; PROMIS-Dyspnea scores are referenced to a chronic obstruc-
tive pulmonary disease (COPD) sample. Results: The 275 survey participants 
showed worse mean PROMIS-29 scores than the general population in all meas-
ured domains (mean value: anxiety= 63.9; depression= 61.9; fatigue= 60.1; pain= 62.6; 
sleep disturbance= 55.8; physical function= 36.2; social role= 42.2). Dyspnea severity 
was associated with worse mean PROMIS-29 scores (all p< 0.05). PROMIS-Dyspnea 
(mean= 58.7) and Functional Limitations Due to Dyspnea (mean= 58.4) scores were 
worse than the COPD reference population. Cough severity was associated with 
worse HRQOL measured by ATAQ-IPF. Reliability of PROMIS-29 scores exceeded 0.65 
and were moderately correlated with measures of similar constructs. A limitation 
of the study is that data drawn from a sample from advocacy organizations might 
not be generalizable to the entire IPF population. ConClusions: Patients with IPF 
report substantial deficits in HRQOL, particularly with respect to physical function, 
anxiety, pain, depression and fatigue. Patients suffering from dyspnea and cough 
had poorer HRQOL. These deficits should be monitored in clinical practice and 
evaluated in investigational trials aiming to improve the HRQOL of IPF patients.
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objeCtives: To analyze the impact that asthma and chronic obstructive pulmo-
nary disease (COPD) have on patients Health Related Quality of Life (HRQOL) and 
on health resources consumed by the Spanish Health System. Methods: Data 
obtained from the last Spanish National Health Survey (SNSHS) 2011-12, on adult 
population (> 15y), identifying patients with a diagnostic of asthma or COPD. 
Descriptive statistic analysis was carried out, specially focused on self-reported 
HRQOL (EQ-5D-5L) and health resources utilization. The EQ-5D results were trans-
lated into QALYs, with the social tariffs validated in Spain. Other demographic 
